This study highly implicates N‐cadherin as a valid target for treatment of human PCa, and suggests that N‐cadherin antagonists such as ADH‐1 and Tel that target its adhesive function should be developed for use in treatment of human PCa. The gene discussed is ETV6; the disease is posterior cortical atrophy.